CDH17 and neoplasm: Furthermore, dual cadherin antibodies recognizing CDH1 (epithelial E‐cadherin) and CDH11 (mesenchymal OB‐cadherin) have been reported to target circulating tumor cells and inhibit bloodborne metastasis in breast and pancreatic cancers [16].